Trial site

Yuge Hospital

Kumamoto, 861-8002, JapanNot linked to an institution yet

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions: Schizophrenia3 trials
Depression1 trial
Phase: Phase 33 trials
Phase 21 trial
Status: Recruiting3 trials
Active, not recruiting1 trial
Lead sponsor: Eli Lilly and Company2 trials
Bristol-Myers Squibb1 trial
Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507· Phase 2· Eli Lilly and Company· Source
Contact: Masahiro Shono (principal investigator)
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756· Phase 3· Eli Lilly and Company· Source
Contact: Masahiro Shono (principal investigator)
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
NCT06882785· Phase 3· Bristol-Myers Squibb· Source
Contact: Masahiro Shono, Site 0011
Active, not recruiting
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
NCT06894212· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 12 Nov 2026